As of 30 Sep 2025, 10 institutional investors reported holding 58,138 shares of Xenetic Biosciences, Inc. - COM (XBIO).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 2 | $4 | $2.00 | 1 | |
| 2025 Q3 | 58,138 | $183,741 | -$25,655 | $3.15 | 10 |
| 2025 Q2 | 64,211 | $250,169 | -$109,737 | $3.92 | 9 |
| 2025 Q1 | 107,313 | $292,493 | +$46,588 | $2.61 | 12 |
| 2024 Q4 | 89,447 | $356,049 | +$160,445 | $4.00 | 12 |
| 2024 Q3 | 48,734 | $211,621 | +$146,292 | $4.34 | 9 |
| 2024 Q2 | 14,882 | $62,048 | -$18,274 | $4.07 | 5 |
| 2024 Q1 | 19,610 | $73,775 | +$10,085 | $3.77 | 7 |
| 2023 Q4 | 16,935 | $60,671 | +$50,633 | $3.45 | 7 |
| 2023 Q3 | 2,700 | $8,000 | -$102,085 | $2.96 | 1 |
| 2023 Q2 | 36,642 | $120,375 | +$120,375 | $3.28 | 9 |